Document is current
Any future updates will be listed below
-
Authors
Birtle, Alison J. https://orcid.org/0000-0002-2621-0909
Formisano, Luigi
Descamps, Vincent
Weisenseel, Peter
Vilaseca, Antoni https://orcid.org/0000-0003-0160-620X
- License Information
-
More Information
Article History
Received: 23 May 2024
Accepted: 27 June 2024
First Online: 1 August 2024
Ethical Approval
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Patient consent was received for the use of their images.
: Alison Birtle has received advisory board fees from Astellas, Bayer, Roche, BMS, Accelerated Applications, MSD, Merck and AstraZeneca; personal fees, speaker fees and advisory board fees from Sanofi; and personal fees and advisory board fees from Janssen. Vincent Descamps has received fees for consultancy, speaker fees and/or support for travel from Novartis, Sanofi, Lilly, Janssen, Abbvie, Celgene, Amgen, UCB, Almirall and Leo Pharma. Luigi Formisano has received speaking and lecture fees from Merck Sharp and Dohme, Janssen, Novartis, Bristol Myers Squibb and AstraZeneca. Antoni Vilaseca has received honoraria for advisory board meetings, symposiums and travel expenses from Johnson and Johnson, Astellas, Bayer, Recordati and Accord. Peter Weisenseel has received honoraria as consultant or speaker from Janssen.
